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Abstract N→S acyl transfer is a popular method for the post-synthesis 
production of peptide Cα-thioesters for use in Native Chemical Ligation and 
for the synthesis of head-to-tail cyclic peptides.  Meanwhile thioester 
formation at the sidechain of aspartic or glutamic acids, leading to tail-to 
sidechain cyclized species, is less common.  Herein we explore the potential 
for cysteine to function as a latent thioester when appended to the sidechain 
of glutamic acid.  Initial insights gained through study of C-terminal β-alanine 
as a model for the increased chain length were ultimately applied to peptide 
macrocyclization.  Our results emphasize the increased barrier to acyl 
transfer at the Glutamic acid sidechain and indicate how a slow reaction, 
facilitated by cysteine itself, may be accelerated by fine tuning of the 
stereoelectronic environment.   
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Due to the increasing importance of cyclic peptides as 
robust pharmaceutical scaffolds for otherwise metabolically 
fragile bioactive peptides,1 a vast number of chemical and 
biological methods have been reported for their synthesis.  
Despite the multitude of methods accessible to the synthetic 
chemist,2 chemoselective ligation technologies continue to lead 
the way in the quest for scalable and cost-effective protocols.3  
The use of Native Chemical Ligation (NCL, Fig. 1a) to effect 
cyclisation of a linear precursor, adorned with a C-terminal 
thioester and N-terminal cysteine, is arguably the most common 
approach since it can be conducted in water, using unprotected 
peptides, and employ precursors of synthetic or biological 
origin.  Post-synthesis N→S acyl transfer is becoming a common 
method for production of the required thioester component and 
several devices have been developed around the β-amino thiol 
scaffold of cysteine (Cys) to help facilitate it.4  We have mainly 
studied the N→S acyl transfer activity of native peptide 
sequences in particular, where cysteine itself promotes the 
reaction (Fig.1b).   
Having demonstrated the cysteine promoted head-to-tail 
cyclization using synthetic5 and biologically6 produced 
precursors we turned our attention to more challenging 
topologies such as the tail-to-sidechain cyclisation depicted in 
Figure 1c.  This mode of cyclisation is often found in lariat (lasso) 
peptides which have not yet proved amenable to chemical 
synthesis,7 and is particularly interesting because a sidechain 
thioester cannot be introduced by using an intein.  Furthermore, 
conducting thioester formation in aqueous solution using fully 
unprotected, or tethered, lariat precursors may allow the 
peptide to adopt a more native conformation prior to 
cyclization.  Melnyk and co-workers previously showed that acyl 
transfer, when conducted at the sidechain of aspartic acid (Asp) 
or glutatamic acid (Glu), was slow relative to C-terminal 
thioester formation, when using a bis-2-sulfanylethylamino (bis-
SEA) functionalised peptide.8  The difference in reactivity also 
formed the basis for kinetically controlled thioester formation.9  
We were keen to establish whether slow thioester formation 









Figure 1 a) Head-to tail peptide cyclisation enabled by NCL. b) A C-terminal 
cysteine residue promotes N→S acyl transfer, providing transient access to 
the required thioester for cyclisation via NCL. c) Tail-to-sidechain cyclisation 
using a thioester precursor installed on an amino acid sidechain 
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Scheme 1.  Desired peptide motifs derived from Asp (1) or Glu (2) could be 
introduced using e.g  3a/b and an expanded genetic code.  Dipeptide 4 has 
already been genetically encoded, enabling side-chain ubiquitination using 
NCL.  
was used to promote the initial N→S acyl shift and, if so, what 
could be done to remedy it.  Specifically, we set out to examine 
the NS acyl transfer behaviour of branched dipeptide motifs 1 
and 2 (Scheme 1) within the context of a synthetic peptide 
sequence.  If successful the hope would be that these should be 
genetically encodeable via building blocks such as 3a/b.  
Interestingly several branched dipeptides including 4,10 which 
enables site-specific ubiquitination via NCL with ubiquitin 
thioesters, have already been genetically encoded in bacteria 
employing orthogonal pyrrolysyl tRNA/tRNA synthetase pairs 
suggesting that this route could well be plausible. 
To establish how dramatically the additional methylene 
groups between the sidechain carboxyl group of, for example, 
glutamic acid and the peptide backbone influence the reactivity 
of cysteine towards N→S acyl shift, we first compared the 
reactivity glycine terminated model peptide 5a with β-alanine 
terminated peptides 6a and 7a (Figure 2), which served as 
models for the increased chain length.11  We were pleasantly 
surprised to find that thioester 6b could be cleanly formed from 
β-alanine terminated 6a.  However formation of 6b was 
significantly slower when compared with the corresponding 
Gly-Cys-OH motif (5a), taking up to 72 h to reach >70% 
conversion at 60oC.   
Although not surprising, since the Melnyk group reported 
reaction times of 144 h for thioesterification/cyclisation (at 
37oC) with a sidechain SEA motif,8 this raised concerns about the 
use of cysteine itself as a facilitator N→S acyl shift when applied 
to the amino acid side chain and re-emphasised the important 
contribution of the α-amino group of the adjacent non-scissile 
amide in mediating the reactivity of native peptide sequences.  
Keen to reconstitute glycine-like reactivity at β-alanine 
terminated peptide we additionally explored the use of model 
peptide 7a containing αMethyl cysteine because it is more 
susceptible to thiolysis than cysteine itself and, as a 
commercially available amino acid, it is simple to introduce 
relative to common alternatives.12 Furthermore, since the 
desired dipeptide motifs that would need to be introduced in 
order to effect side-chain activation (e.g. 3) are not naturally 
occurring there was no need to retain a strict cysteine scaffold.  
The model reaction employing 7a was extremely encouraging 
showing almost complete consumption of the starting material 
within 6 h. 
We postulated that the reduction in reaction rate, when 
using β-Ala, was likely due to the increased distance between 
the reaction site and the proximal electron withdrawing amide 
nitrogen atom.  To explore this further we examined whether 
reactivity could be restored through introduction of an 
electronegative atom, such as fluorine, placed alpha to the 
carbonyl group of the scissile amide bond (Figure 3).  
Consequently we prepared fluorinated peptides 8a and 9a.  
Monofluorinated 8a was prepared as an epimeric mixture from 
racemic 2-fluoro-β-alanine.  The epimers were almost 
completely separated by HPLC, appeared configurationally 
stable under the reaction conditions and both behaved similarly 
in reactions.  Analysis of reaction mixtures after 24 h indicated 
that the fluoro-β-alanine residues installed at the C-terminus 
indeed accelerated the rate of thioester formation relative to β-
alanine itself.   However what also became evident was that 
thioesters 8b and 9b were unstable and more prone to 
hydrolysis.  After 24 h the initially formed thioester product 8b 
was almost completely hydrolysed at 60 oC.  Hydrolysis could be 
reduced, but not abolished, by conducting the reaction at 50 or 
40 oC (Figure 3a) but, when using 9a, a thioester product could 
not be observed at all.  However the reactive nature of the 2-
fluoro-β-Ala-Cys-OH motif prompted us to investigate the 
reaction further since we were confident that, by intercepting 
the intermediate with a nucleophilic species such as hydrazine 
or creating a more stable product via in-situ cyclisation,5d we 








Figure 2 a) comparison of MESNa thioester formation across Gly-Cys-OH (H-MEELKYSGC-OH, 5a), βAla-Cys-OH (H-MEELYKSβAC-OH, 6a), and βAla-αMeCys-OH (H-
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Figure 3 Cysteine promoted thioester and hydrazide formation at glycine (5a), β-alanine (6a), and fluorinated analogues (8a, 9a)  a) After 24 h at 50 oC in the absence of 
hydrazine.  b)  After 24 at 50 oC in the presence of hydrazine. * corresponds to the hydrolysis product as identified by LC-MS. 
as expected, 8a and 9a formed acyl hydrazides 8c/9c cleanly 
and near quantitatively at 50 oC after 24 when the reaction 
mixture was supplemented with 5% w/v hydrazinium acetate,13 
appearing superior both β-Ala-Cys-OH and Gly-Cys-OH 
terminated peptides (Figure 3b).  Curious as to whether the 
successful outcome indicated that cyclisation may prove more 
productive than thioester formation a model peptide 
corresponding to an analogue of the plasmin inhibitory peptide, 
Agardhipeptin A,14 was readily assembled. As with 8a, the 
racemic monofluorinated β-Ala residue was employed but, in 
contrast to 8a, the Agardhipeptin A analogue 10a did not yield 
an easily separable mixture of epimers.  Since this was 
considered to be of little consequence for the purpose of the 
experiment the progress of the reaction was monitored using 
the summed peak areas of each epimer for the starting material 
and product.  In the cyclisation reaction only the linear 
precursor containing a monofluorinated β-Ala residue gave rise 
to a cyclic peptide (Figure 4) whereas the precursor containing 
the difluorinated β-Ala showed only hydrolysis under identical 
reaction conditions.   
Overall, the results of model experiments using β-alanine 
and fluorinated derivatives were extremely enlightening 
showing, not only how an additional methylene group placed 
between the scissile amide bond and the adjacent α-amino 
group reduced reactivity, but additionally how reactivity could 
be restored by introduction of a single fluorine atom.  Whilst 
thioesters 8b, and 9b appeared unstable, we demonstrated how 
they could be efficiently trapped by added nucleophiles such as 
hydrazine, which may well find new applications in the future.  
However, regardless of how encouraging the cyclisation of 10a 
appeared, we were not keen to progress the monofluorinated β-
alanine derivatives as acyl transfer precursors.  Since the 
fluorine atom would be retained by the product, a scalable and 
enantioselective synthesis of a corresponding monofluorinated 
glutamic/aspartic acid would need to be conducted.  Although 
enantioselective routes to monofluorinated glutamic acids exist 
from hydroxyproline,15 pyroglutamic acid derivatives,16 and 
more recently from the -aldehyde,17 their synthesis is difficult 
to scale, employing expensive and/or toxic metals and catalysts.  
Furthermore, having already achieved acceptable results with 
6a and improved results with 7a we felt sufficiently confident to 
explore the reactivity of the -glutamyl cysteine containing 
peptides themselves.  Due to the potential for aspartimide 
formation upon activation of aspartic acid derivative 1 we 
initially focussed on the synthesis and reactivity of the -
glutamyl cysteine motif  2. 
Previous investigations employing cysteine as the sole 










Figure 4 Cyclisation of Agardhipeptin A analogues in 0.7 M MESNa at 60 oC 
from linear precursors H-CHGWPWGX-OH, where X = Gly (10a) or 2-fluoro β-
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Scheme 2.  Synthesis of suitably protected branched dipeptides 16a and 16b.    
the branching cysteine residue should possess a free carboxyl 
group.18 Consequently it was important to differentiate the α-
carboxyl groups of cysteine and glutamic acid in the dipeptide 
building block such that the α-carboxyl group of glutamic acid 
could be unmasked for solid phase peptide synthesis while the 
α-carboxyl group of cysteine remained protected (Scheme 2).  
Suitably protected dipeptide building blocks 16a/b were 
readily prepared from available H-Cys-OH, or H-αMeCys-OH, 
and Fmoc-Glu-OAll.  Briefly, the free amino acids were converted 
to the STrt/Nα-Fmoc protected derivatives 13a/b by overnight 
reaction with trityl chloride in DMF followed by reaction of the 
crude product with Fmoc succinimide in 1:1 water/dioxane in 
the presence of excess Na2CO3 (Fmoc-Cys(Trt)-OH is also 
commercially available).12  Introduction of the cysteinyl Cα tert-
butyl ester was next introduced according to the method 
reported by Schmidt,19 using tert-butyl 2,2,2-
trichloroacetimidate (TBTA) in the presence of BF3.OEt2 to 
afford fully the protected amino acid. Subsequent Fmoc 
deprotection with piperidine in DCM liberated the free α-amino 
group for coupling to the -carboxyl of commercially available 
Fmoc-Glu-OAll, which was efficiently completed using pyBOP as 
coupling reagent in the presence of DIPEA.20  The desired 
building blocks, Fmoc-Glu[Cys(Trt)OtBu]-OH (16a) and Fmoc-
Glu[αMeCys(Trt)OtBu]-OH (16b) were ultimately prepared 
upon Pdo catalysed cleavage of the allyl ester from 15a/b.21 
Whether using Cys or αMeCys identical procedures could be 
used throughout and, with the exception of coupling to the 
glutamic acid derivative and Allyl deprotection, yields for the 
αMeCys derivatives were comparable.   
Dipeptides 16a and 16b were next incorporated in place of 
Glu8 into the nine N-terminal residues of antimicrobial lariat 
peptide microcin J25 to afford 17 and 18 respectively (Figure 
5).  Although this partial sequence is incapable of forming the 
characteristic lariat structure of microcin J25,22 it served as a 
suitable model system to test the tail-to-sidechain cyclization.  
In agreement with preceding results cyclization of 17 similarly 
showed that the desired peptide macrocycle could be formed in 
greater that 70 % yield (as judged by HPLC) over 72 h at 50 oC, 
validating the use of β-alanine as a model system.  While 
encouraging, we ultimately believed that the long reaction time 
at elevated temperature would be generally detrimental to the 
formation of sidechain thioesters and tail-to-sidechain 
cyclisation reactions in more complex samples.  Encouragingly 
peptide 18 also behaved similarly to the preceding model 
experiments.  While the reaction to form 1923 took nearer 24 h 
to reach 92% conversion at 50 oC (compared with ca. 6 h at 60 
oC in β-Ala experiments) it appeared that thioester formation 
had advanced significantly within 6 h, as indicated by the 
appearance and subsequent consumption of the MESNa 
thioester intermediate (marked with an asterisk in Fig. 5b).  It is 
likely that NCL cyclisation under non-ideal conditions (pH <7) is 
the reason for the accumulation of the MESNa thioester. 
In conclusion cysteine, when installed at the side chain 
carboxyl group of glutamic acid, was found to be a willing 
facilitator of N→S acyl transfer, albeit with reduced efficiency 
when compared with presentation at the C-terminus.  Based on 
previous work by Melnyk and co-workers, as well as our own 
examination of β-Ala terminated model peptides this was not 
particularly unexpected, however reactivity could be 
reconstituted by employing more reactive acyl transfer 
precursors 7a and 18 containing recently described α-
methylcysteine.  Interestingly, researchers have mainly sought 
to elevate the reactivity of thioester precursors towards N→S 
acyl transfer by modification of the cysteine-like C-terminus.  In 
contrast here we have shown that N→S acyl transfer can also be 
enhanced by electronic activation of the adjacent residue 
offering new opportunities, more generally, to promote 
controlled fragmentation of peptides under mild conditions.  
Installation of a single α-fluorine atom conferred Gly-Cys like 
properties on otherwise sluggish β-Ala-Cys terminated 
peptides, whereas introduction of a geminal difluoro motif 
appeared too reactive to support thioester formation.  







Figure 5 a) cyclisation of branched precursor peptides 17 and 18 at 50 oC in the presence of 0.7 M MESNa.  b)  HPLC monitoring of the cyclisation of 18 to afford 19 
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may yet serve as useful promoters of N→S acyl transfer across 
FlXaa-Cys motifs in future. 
Overall the selective activation of the glutamic acid sidechain 
using unprotected peptides in aqueous solution, and in the 
context of McJ25, paves the way to a potentially viable route to 
lariat peptides. Selective acyl transfer reactions, likely working in 
combination with a tethering strategy to template the lariat 
fold,24 may ultimately bring this fascinating class of peptides 
under the routine command of the synthetic chemist. 
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oC for 24 h.  The cyclic peptide was then purified from the reaction 
mixture by preparative HPLC.  tR = 26.5 min, and lyophilized to 
afford the pure product as fluffy white solid: ESI+ MS (m/z) calc. 
912.4 found [MH]+ 913.2 Da.  
(24) Sohma, Y.; Hua, Q.-X.; Whittaker, J.; Weiss, M. A.; Kent, S. B. H. 
Angew. Chem. Int. Ed. 2010, 49, (32), 5489-5493. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
